skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon
Pharma Intelligence brings you critical pharmaceutical research studies, featuring new pharmaceutical research developments, and delivers them to you in a timely fashion. Rely on the experienced experts from Pharma Intelligence for essential information and unparalleled insights you can use to inform your own business decisions and strategies.

Don't miss any of the impactful developments to come out of ESMO 2019

Follow all the highlights from this annual meeting of oncology clinicians, researchers, patient advocates, journalists, and members of the pharmaceutical industry with this report extract. Datamonitor Healthcare’s coverage includes:

• Translational cancer science unveiled at ESMO 2019
• Announcements of potentially practice-changing data
• Important developments from the 5-day event


PharmAI – Industry Is Smartening Up To Potential Of Artificial Intelligence

Artificial Intelligence (AI) has enormous potential in changing the delivery of health care and improving patient outcomes, with applications in pattern detection, patient monitoring, disease diagnosis and treatment selection. The rationale is that AI can be used to enhance the decisionmaking process, taking into account far more data than are available to physicians via conventional means. The addition of machine learning (ML)algrithms enables the AI to become better over time, increasing the accuracy or timeliness of its recommendations. Recognizing this broad potential, the FDA has recently sought to spur the industry with its discussion paper on regulating Software as a Medical Device (SaMD) products.

Disease overview

Payers have become increasingly aware of the potential cost burden of multiple myeloma treatment over the past five years, due to several factors:

  • The approvals of several high-cost biologics in increasingly early treatment lines
  • Increased patient life expectancies resulting in extended treatment durations
  • The surge in demand for high-cost combination regimens


  • 世界の薬事規制動向&情報を配信

    Pink Sheet – US Election and New Administration Coverage

    Stay informed of the latest news from the recent US election and understand how the shift in power will affect pharma regulatory and policy issues both within the United States and abroad. Pink Sheet takes you behind the US election headlines for analysis on the real impact you can expect to see on your business.

    Topic us-election-2020

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価, Scrip: 世界の医療用医薬品&製薬産業に関するニ...

    39th Annual J.P. Morgan Healthcare Conference 2021

    39th Annual J.P. Morgan Healthcare Conference 2021

    Keep up with events as they unfold at the 39th Annual J.P. Morgan Annual Healthcare Conference on January 11-14, 2021. Pharma Intelligence and Insights journalists will bring you real time reporting, highlighting important events and key takeaways from every day of the largest and most informative healthcare investment symposium in the industry.

  • Datamonitor Healthcare: 医療用医薬品の市場調査レポート



    Topic Coronavirus vaccines

  • In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース

    Pharma Intelligence Insights – Outlook 2021 Report

    Power your strongest strategy for the year ahead with insights from the Outlook 2021 report. A combination of Scrip’s Scrip 100, Medtech Insight’s Medtech 100, and In Vivo’s Outlook reports, Outlook 2021 is a comprehensive window into the key trends, challenges and opportunities impacting the biopharma, medtech, and generics sectors for the year to come.

    Topic Outlook

  • Pink Sheet: 世界の薬事規制と承認審査に関するニュース

    With US Senate Wins In Georgia, Democrats Gain Path For Rx Price Reform, But It May Be Lower Priority


    Razor-thin majorities in both chambers of Congress mean Democrats can’t enact a bold agenda, and the pandemic and attendant recession mean that the initial legislative focus won’t be on Rx issues.

  • Scrip: 世界の医療用医薬品&製薬産業に関するニュース

    First In World COVID-19 Vaccine For Kids Below 12?

    First In World COVID-19 Vaccine For Kids Below 12?

    Could Serum Institute or Bharat Biotech be the first company to have a COVID-19 vaccine for children under 12 years of age? While Pfizer and Moderna have begun pediatric trials for children 12 years and above, Serum plans to begin testing its indigenous vaccine and Bharat Biotech its Covaxin in children under 12

    Topic Coronavirus

  • Pink Sheet: 世界の薬事規制と承認審査に関するニュース

    UK Vaunts 'New Era' In Drug Approvals


    The UK regulator, the MHRA, has published guidance on its new integrated pathway for innovative drug approvals, which it says is intended to bring together partners including health technology assessment agencies, health care bodies and patient organizations to offer “sustained collaboration” with drug developers.

  • Scrip: 世界の医療用医薬品&製薬産業に関するニュース

    How COVID-19 Defined 2020 For Biopharma


    Development of vaccines usually takes years, but drug makers whittled the process down to a matter of months amid a concerted response to a global health threat.

    Topic Coronavirus

  • Medtech Insight: 世界の医療機器・医療技術の最新情報

    MedTech Summit 2020

    The annual Medtech Summit was held online in 2020, and Medtech Insight was there, reporting on the presentations from more than 100 top medical device, diagnostic, and combination product speakers and 15+ Competent Authority and Notified Body representatives. In all, over 50 hours of live and on-demand sessions with critical information and guidance were presented. 

    Topic Medtech

  • Medtech Insight: 世界の医療機器・医療技術の最新情報

    MedTech Summit 2020

    Medtech Summit Article Pack

    The annual Medtech Summit was held online in 2020, and Medtech Insight was there, reporting on the presentations from more than 100 top medical device, diagnostic, and combination product speakers and 15+ Competent Authority and Notified Body representatives. In all, over 50 hours of live and on-demand sessions with critical information and guidance were presented. 

    Topic Medtech

  • Datamonitor Healthcare: 医療用医薬品の市場調査レポート, Biomedtracker: 開発中医...




    Topic Coronavirus Clinical Trials

  • Medtech Insight: 世界の医療機器・医療技術の最新情報, Meddevicetracker: 医療機器の市...

    Meddevicetracker & Medtech Insight Spinal Device Markets

    Discover what’s on the horizon for spinal devices and technology with news, analysis, and data from Medtech Insight and Meddevicetracker. Keep up with the latest developments from the annual NASS meeting and explore extracts from two data-packed recent reports: Spinal Fusion Implanted Instrumentation and Spinal Motion Preservation Devices Market.

  • Citeline, Sitetrove: 治験責任医師と治験施設情報のデータベース, Trialtrove: 医療用医薬...

    Achieve Clinical Trial Success with Sitetrove and Trialtrove

    Achieve Clinical Trial Success with Sitetrove and Trialtrove

    Even one misstep in your clinical trials strategy or execution can cost your company millions. Save time and cost with the trusted source for global investigator and site intelligence and global pharmaceutical clinical trial intelligence by subscribing to Sitetrove and Trialtrove.

    Topic clinical-trials Coronavirus

  • Citeline

    Clinical Trials & the COVID-19 Vaccine

    COVID-19 Pulse report

    Informa Pharma Intelligence’s Pulse Report

    Topic Coronavirus clinical-trials

  • Pink Sheet: 世界の薬事規制と承認審査に関するニュース

    US FDA's COVID Whirlwind: Pfizer Vaccine Adcom Set; Monoclonal EUAs Cleared; Trump Aggrieved

    FDA Miss Deadline

    Warp Speed’s Slaoui predicts vaccinations starting within days of the 10 December advisory committee for Pfizer’s coronavirus vaccine. Regeneron’s monoclonal cocktail follows Lilly’s antibody product with an EUA.

    Topic Coronavirus FDA

Data and analysis products


Sitetrove: 治験責任医師と治験施設情報のデータベース

Sitetrove(サイトトローブ)は、170か国・40万人以上の治験責任医師(PI: Principal Investigator)と235以上の疾患に対応する11万7千か所以上の治験施設に関する情報を収録するデータベースです。治験責任医師と治験施設に関して業界で最も正確で包括的な情報を提供することで、コスト増につながる治験の遅延を最小化し、お客様の臨床試験を成功に導くようサポートします。Sitetroveに登録される治験責任医師は、豊富な臨床経験や治験に関する十分な知識をもっていることをアナリストにより精査されています。

Key benefits:

  • 治験責任医師と治験施設情報のデータベース
  • 疫学ダッシュボードは見やすいマップビュー
  • アナリストに
data-monitor-health-care-pharma intelligence


Datamonitor Healthcare(データモニターヘルスケア)では主要な疾患と医薬品をカバーする市場調査レポートを収載し、定期的に更新しています。市場調査レポート1本単位の購入または疾患単位の購読契約による対象の市場調査レポートすべての閲覧が可能です。新医薬品の市場性の評価や研究開発戦略の立案にご利用ください。

Key benefits:

  • 見識者による
  • 最先端ツールで
  • アナリストに
pharma intelligence pharma banner



Key benefits:

  • 世界の医薬品
  • 過去40年以上の
  • アナリストに